Rescue photodynamic therapy for age-related macular degeneration refractory to anti-vascular endothelial growth factor monotherapy
- 2 February 2022
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 38, 102745
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- THREE-YEAR RESULTS OF POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH PHOTODYNAMIC THERAPYRetina, 2015
- One-Year Result of Aflibercept Treatment on Age-Related Macular Degeneration and Predictive Factors for Visual OutcomeAmerican Journal of Ophthalmology, 2015
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degenerationBritish Journal of Ophthalmology, 2014
- Combination Therapy for Neovascular Age-related Macular Degeneration Refractory to Anti-Vascular Endothelial Growth Factor AgentsOphthalmology, 2013
- AfliberceptNature Reviews Drug Discovery, 2012
- Choroidal Thickness in Polypoidal Choroidal Vasculopathy and Exudative Age-related Macular DegenerationOphthalmology, 2011
- Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 2011
- Enhanced Depth Imaging Spectral-Domain Optical Coherence TomographyAmerican Journal of Ophthalmology, 2008
- HEMORRHAGIC COMPLICATIONS AFTER PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHYRetina, 2007
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE) IN PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES: UPDATERetina, 2005